Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • Novel DNA-based Immunotherapy for Neutralizing Hepatitis B Virus infection, The Wistar Institute

Novel DNA-based Immunotherapy for Neutralizing Hepatitis B Virus infection, The Wistar Institute

8 Jun 2020 11:00 AM | Anonymous

Scientists at The Wistar Institute developed a synthetic DNA approach that instructs in vivo production of a human monoclonal antibody able to neutralize hepatitis B virus (HBV) and prevent infection of liver cells in vitro.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software